Blue Jet Healthcare Ltd vs Novartis India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 421.55 as of 18 May 15:30 . The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 .The P/E Ratio of Novartis India Ltd is 0 as of March 2021 . The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Novartis India Ltd is ₹ 0 crore as of March 2021 . The revenue of Blue Jet Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 205.62 crore. This represent the decline of -100% The revenue of Novartis India Ltd for the Mar '26 is ₹ 100.56 crore as compare to the Dec '25 revenue of ₹ 94.65 crore. This represent the growth of 6.24% The ebitda of Blue Jet Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 60.1 crore. This represent the decline of -100% The ebitda of Novartis India Ltd for the Mar '26 is ₹ 30.63 crore as compare to the Dec '25 ebitda of ₹ 31.11 crore. This represent the decline of -1.54% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 25.25 crore over 8 quarters. This represents a CAGR of -0.96% The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 yearsThe Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 years .

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

FAQs for the comparison of Blue Jet Healthcare Ltd and Novartis India Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Novartis India Ltd?

Market cap of Blue Jet Healthcare Ltd is 7,312 Cr while Market cap of Novartis India Ltd is 2,914 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Novartis India Ltd?

The stock performance of Blue Jet Healthcare Ltd and Novartis India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Novartis India Ltd?

As of May 18, 2026, the Blue Jet Healthcare Ltd stock price is INR ₹421.55. On the other hand, Novartis India Ltd stock price is INR ₹1180.5.

How do dividend payouts of Blue Jet Healthcare Ltd and Novartis India Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Novartis India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.